| Full Name |
Epstein-Barr Virus (HHV)-4 p23 Protein, Recombinant
|
Abbreviated Name-1 |
EBV p23; EBV p-23; Epstein-Barr Virus (HHV-4) p23; Epstein-Barr Virus (HHV-4) p-23 |
| Documents |
|---|
| Figures |
|---|
| Reference |
|---|
Mills R, et al. Improving gene annotation of complete viral genomes. Nucleic Acids Res. Dec 2003; 31(23): 7041-7055.
Bowman BR, et al. Structural characterization of the UL25 DNA-packaging protein from herpes simplex virus type 1. J. Virol. Mar 2006; 80(5): 2309-2317.
Davison AJ, Stow ND. New genes from old: redeployment of dUTPase by herpesviruses. J. Virol. Oct 2005; 79(20): 12880-12892.
|
|
Description |
Epstein-Barr Virus (HHV)-4 p23 is an E. coli-derived recombinant. The mosaic protein Epstein-Barr Virus (HHV)-4 p23 contains the HHV-4 p23 regions. EBV p23 is a viral late complex associated with virion particles and consists of two gene products, BFRF3 and BLRF2. |
Source |
E. coli |
Purity |
Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
Storage |
Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
Concentration |
1 mg/ml in 25 mM glycine, pH9.6, 50% glycerol. |
Stability |
Five years frozen. One month in solution at room temperature. |
Specificity |
Immunoreactive with sera of EBV-infected individuals. |
Applications |
Antigen in ELISA and Western blots, excellent antigen for detection of HHV-4 (EBV)- with minimal specificity problems. |
Note |
; |
